<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: Telomeres play a key role in the maintenance of chromosome integrity and stability, and telomere shortening is involved in initiation and progression of <z:e sem="disease" ids="C0006826" disease_type="Neoplastic Process" abbrv="">malignancies</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>The aim of this study was to determine whether telomere length is associated with the colorectal <z:mp ids='MP_0002038'>carcinoma</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>PATIENTS AND METHODS: A total of 148 colorectal <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) samples and corresponding adjacent non-cancerous tissues were evaluated for telomere length, P53 mutation, and cyclooxygenase-2 (COX-2) mutation detected by fluorescent immunohistochemistry </plain></SENT>
<SENT sid="3" pm="."><plain>Telomere length was estimated by real-time PCR </plain></SENT>
<SENT sid="4" pm="."><plain>Samples with a T/S&gt;1.0 have an average telomere length greater than that of the standard DNA; samples with a T/S&lt;1.0 have an average telomere length shorter than that of the standard DNA </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Telomeres were shorter in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> than in adjacent tissues, regardless of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> stage and grade, site, or genetic alterations (P=0.004) </plain></SENT>
<SENT sid="6" pm="."><plain>Telomere length in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRCs</z:e> also had differences with COX-2 status (P=0.004), but did not differ with P53 status (P=0.101), <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e> (P=0.244), gender (P=0.542), and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> (0.488) </plain></SENT>
<SENT sid="7" pm="."><plain>There was no clear trend between T/S optimal cut-off values (&lt;1 or &gt; 1) and <z:e sem="disease" ids="C0009404" disease_type="Neoplastic Process" abbrv="">colorectal tumor</z:e> progression, <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e>, gender, P53 and COX-2 status </plain></SENT>
<SENT sid="8" pm="."><plain>CONCLUSION: These findings suggesting that telomere shortening is associated with colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> but does not differ with <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, gender, and <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> </plain></SENT>
</text></document>